Literature DB >> 15100283

Helper requirements for generation of effector CTL to islet beta cell antigens.

Georg M N Behrens1, Ming Li, Gayle M Davey, Janette Allison, Richard A Flavell, Francis R Carbone, William R Heath.   

Abstract

We have dissected the helper requirements for converting a tolerogenic CD8 T cell response into one capable of causing destruction of the pancreatic islets. Injection of naive OVA-specific CD8 T cells into transgenic mice expressing OVA in the pancreas only resulted in islet destruction when activated CD4 Th cells were coinjected. This requirement for activated CD4 T cell help for induction of primary CD8 T cell-mediated immunity to tissue Ags contrasts recent reports suggesting that help is only important for CTL memory. Our findings show that signaling of CD40 on the dendritic cell presenting to CD8 T cells is important, but not sufficient, for induction of diabetes. Furthermore, once helpers are activated, they need not recognize Ag on the dendritic cells they license. This provides insight into the helper requirements for adoptive transfer immunotherapy of tumors and suggests key points for inhibition of CTL-mediated autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100283     DOI: 10.4049/jimmunol.172.9.5420

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets.

Authors:  Arno Hänninen; Rita Nurmela; Mikael Maksimow; Jarkko Heino; Sirpa Jalkanen; Christian Kurts
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  New roles revealed for T cells and DCs in glomerulonephritis.

Authors:  Alfred H J Kim; Mary A Markiewicz; Andrey S Shaw
Journal:  J Clin Invest       Date:  2009-05       Impact factor: 14.808

Review 3.  Unravelling the mechanisms of help for CD8+ T cell responses.

Authors:  Alexandra M Livingstone; Elizabeth B Wilson; Fernando Ontiveros; Jyh-Chiang E Wang
Journal:  Immunol Res       Date:  2009-02-18       Impact factor: 2.829

Review 4.  CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.

Authors:  Paul Andrew Antony; Nicholas P Restifo
Journal:  J Immunother       Date:  2005 Mar-Apr       Impact factor: 4.456

5.  Peripheral Deletion of CD8 T Cells Requires p38 MAPK in Cross-Presenting Dendritic Cells.

Authors:  Trevor Smith; Xiaotian Lin; Marielle Mello; Kristi Marquardt; Jocelyn Cheung; Binfeng Lu; Linda A Sherman; Grégory Verdeil
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

6.  CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity.

Authors:  Thomas Calzascia; Marc Pellegrini; Albert Lin; Kristine M Garza; Alisha R Elford; Arda Shahinian; Pamela S Ohashi; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-14       Impact factor: 11.205

7.  Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.

Authors:  Ying Xie; Akgül Akpinarli; Charles Maris; Edward L Hipkiss; Malcolm Lane; Eun-Kyung M Kwon; Pawel Muranski; Nicholas P Restifo; Paul Andrew Antony
Journal:  J Exp Med       Date:  2010-02-15       Impact factor: 14.307

8.  IL-2 mediates CD4+ T cell help in the breakdown of memory-like CD8+ T cell tolerance under lymphopenic conditions.

Authors:  Cécile Le Saout; Marine Villard; Clémence Cabasse; Chantal Jacquet; Naomi Taylor; Javier Hernandez
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

9.  Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells.

Authors:  Nicholas M Provine; Rafael A Larocca; Malika Aid; Pablo Penaloza-MacMaster; Alexander Badamchi-Zadeh; Erica N Borducchi; Kathleen B Yates; Peter Abbink; Marinela Kirilova; David Ng'ang'a; Jonathan Bramson; W Nicholas Haining; Dan H Barouch
Journal:  J Immunol       Date:  2016-07-22       Impact factor: 5.422

10.  Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury.

Authors:  Felix Heymann; Catherine Meyer-Schwesinger; Emma E Hamilton-Williams; Linda Hammerich; Ulf Panzer; Sylvia Kaden; Susan E Quaggin; Jürgen Floege; Hermann-Josef Gröne; Christian Kurts
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.